BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10711987)

  • 1. Facioscapulohumeral dystrophy.
    Kissel JT
    Semin Neurol; 1999; 19(1):35-43. PubMed ID: 10711987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
    Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
    Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
    Su Q; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
    Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
    Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
    Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
    J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
    Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
    Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic elevation of serum creatine kinase leading to the diagnosis of 4q35 facioscapulohumeral muscular dystrophy.
    Zouvelou V; Manta P; Kalfakis N; Evdokimidis I; Vassilopoulos D
    J Clin Neurosci; 2009 Sep; 16(9):1218-9. PubMed ID: 19502063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy.
    Goto K; Nishino I; Hayashi YK
    Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facioscapulohumeral dystrophy presenting as infantile facial diplegia and late-onset limb-girdle myopathy in members of the same family.
    Felice KJ; Jones JM; Conway SR
    Muscle Nerve; 2005 Sep; 32(3):368-72. PubMed ID: 15880682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FSHD-like patients without 4q35 deletion.
    Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
    J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic investigations in facioscapulohumeral muscular dystrophy: a preliminary report].
    Dorobek M; Kabzińska D; Ryniewicz B; Fidziańska-Dolot A; Hausmanowa-Petrusewicz I
    Neurol Neurochir Pol; 2004; 38(2):83-8. PubMed ID: 15307599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
    Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pushing the genetic frontier with facioscapulohumeral muscular dystrophy.
    Greenberg SA; Padberg GW
    Neurology; 2007 Feb; 68(8):544-5. PubMed ID: 17310022
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic analysis of facioscapulohumeral muscular dystrophy (FSHD)].
    Goto K; Song MD; Lee JH; Arahata K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1416-8. PubMed ID: 8752415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.
    Attarian S; Salort-Campana E; Nguyen K; Behin A; Andoni Urtizberea J
    Rev Neurol (Paris); 2012 Dec; 168(12):910-8. PubMed ID: 22551571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy.
    van Overveld PG; Enthoven L; Ricci E; Rossi M; Felicetti L; Jeanpierre M; Winokur ST; Frants RR; Padberg GW; van der Maarel SM
    Ann Neurol; 2005 Oct; 58(4):569-76. PubMed ID: 16178028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of fascioscapulohumeral muscular dystrophy misdiagnosed as Becker's muscular dystrophy for 20 years.
    Ramos VF; Thaisetthawatkul P
    Age Ageing; 2012 Mar; 41(2):273-4. PubMed ID: 21795275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.